OCRF Statement on OVA1
OCRF Statement on OVA1
Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1. OVA1 is a test approved by the FDA which measures the … Continued
Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1. OVA1 is a test approved by the FDA which measures the … Continued
01/29/2010 Each year, OCRF awards millions of dollars in grants to researchers who are working to beat ovarian cancer. Our two newest grantees, Dr. Lin Zhang and Dr. Kathryn Terry, … Continued
06/08/2009 Last weekend a European study regarding the use of CA 125 testing in ovarian cancer patients was presented at the American Society of Clinical Oncologists (ASCO) Annual Meeting. The … Continued
03/17/2009 Today, the Ovarian Cancer Research Fund (OCRF) announced its most recent research grant recipients. Grants were awarded in three different categories: the Program Project Development Grant, the Liz Tilberis … Continued
On February 5, 2009, OCRF, in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named … Continued
Anil Sood, MD, Principal Investigator of the MD Anderson Cancer Center Program Project Development Grant, is featured in the December 17 Wall Street Journal article "Cancer Study Explores Role of 2 Proteins."
OCRF Partners with GCF to Continue Ovarian Cancer Symptoms Research Gynecologic Cancer Foundation Bulletin Summer 2008
On June 13, 2007, the New York Times published the article “Symptoms Found for Early Check on Ovary Cancer”. The front page article stressed the importance for women and doctors to be familiar with the early symptoms of ovarian cancer, previously believed to have no warning until in its advanced stages.
Get email updates about research news, action alerts, and ways to join the fight.